This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Infinity Pharmaceuticals Inc (INFI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 307.40M 68.11M 175.74M 24.20M
Receivables 647.00K 0.00 0.00 218.19K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 1.99M 0.00 0.00 0.00
Total Current Assets 344.57M 224.94M 329.75M 117.98M
Property, Plant & Equipment, Gross 39.93M 27.30M 27.45M 27.29M
Accumulated Depreciation & Depletion 20.96M 23.29M 23.37M 22.71M
Property, Plant & Equipment, Net 18.97M 4.01M 4.08M 4.58M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 5.61M 1.76M 1.83M 1.93M
Total Non-Current Assets 24.58M 5.77M 5.91M 6.51M
Liabilities & Shareholder Equity
Total Assets 369.14M 230.71M 335.66M 124.49M
Accounts Payable 12.61M 6.38M 8.60M 5.95M
Short Term Debt 0.00 6.67M 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 54.88M 22.21M 18.66M 28.99M
Long Term Debt 0.00 6.46M 0.00 37.55M
Deferred Income Taxes 3.38M 0.00 0.00 0.00
Other Non-Current Liabilities 101.42M 773.00K 6.79M 42.52M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 104.80M 7.23M 6.79M 80.07M
Total Liabilities 159.67M 29.44M 25.46M 109.06M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 209.47M 201.28M 310.20M 15.43M
Common Par 49.00K 48.00K 48.00K 26.72K
Additional Paid In Capital 676.52M 650.87M 633.04M 284.44M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -467.21M -449.80M -323.02M -269.05M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 114.00K 156.00K 134.00K 22.42K
Total Capitalization 209.47M 207.73M 310.20M 52.99M
Total Equity 209.47M 201.28M 310.20M 15.43M
Total Liabilities & Stock Equity 369.14M 230.71M 335.66M 124.49M
Total Common Shares Outstanding 48.88M 48.23M 47.50M 26.72M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 48.56M 47.94M 31.71M 26.62M
Diluted Weighted Shares Outstanding 48.56M 47.94M 31.71M 26.62M
Number of Employees 195 180 154 190
Number of Part-Time Employees 0 0 0 0
INFI News

INFI Infinity Pharmaceuticals Inc

Analysts Ratings for INFI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 5 5 5
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET INFI ANALYST REPORT

Brokerage Partners

INFI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs